Categorias DeCS
A02 Musculoskeletal System .
A02.835 Skeleton .
A02.835.232 Bone and Bones .
A02.835.232.781 Skull .
A02.835.232.781.324 Facial Bones .
A02.835.232.781.324.665 Nasal Bone .
A04 Respiratory System .
A04.531 Nose 16906 .
A04.531.378 Nasal Bone .
C01 Bacterial Infections and Mycoses .
C01.252 Bacterial Infections .
C01.252.400 Gram-Negative Bacterial Infections .
C01.252.400.310 Enterobacteriaceae Infections .
C01.252.400.310.503 Klebsiella Infections .
C01.252.400.310.503.650 Rhinoscleroma .
C01.252.825 Skin Diseases, Bacterial .
C01.252.825.705 Rhinoscleroma .
C01.539 Infection .
C01.539.800 Skin Diseases, Infectious .
C01.539.800.720 Skin Diseases, Bacterial .
C01.539.800.720.705 Rhinoscleroma .
C08 Respiratory Tract Diseases .
C08.460 Nose Diseases .
C08.460.572 Nasal Polyps .
C08.460.850 Rhinoscleroma .
C08.730 Respiratory Tract Infections .
C08.730.702 Rhinoscleroma .
C09 Otorhinolaryngologic Diseases .
C09.603 Nose Diseases .
C09.603.557 Nasal Polyps .
C09.603.850 Rhinoscleroma .
C17 Skin and Connective Tissue Diseases .
C17.800 Skin Diseases .
C17.800.838 Skin Diseases, Infectious .
C17.800.838.765 Skin Diseases, Bacterial .
C17.800.838.765.705 Rhinoscleroma .
C23 Pathological Conditions, Signs and Symptoms .
C23.300 Pathological Conditions, Anatomical .
C23.300.825 Polyps .
C23.300.825.557 Nasal Polyps .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.663 Pyrans .
D03.383.663.283 Benzopyrans .
D03.383.663.283.266 Chromones .
D03.383.663.283.266.300 Cromolyn Sodium .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.150 Benzopyrans .
D03.633.100.150.266 Chromones .
D03.633.100.150.266.300 Cromolyn Sodium .
D20 Complex Mixtures .
D20.280 Colloids .
D20.280.055 Aerosols .
D20.280.055.500 Nasal Sprays .
D26 Pharmaceutical Preparations .
D26.255 Dosage Forms .
D26.255.165 Colloids .
D26.255.165.055 Aerosols .
D26.255.165.055.291 Nasal Sprays .
|
| | Termos Sinônimos e Históricos | Documentos LILACS e MDL | | | | | | | | | | | | | | | | | | | |
|